{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:52:01Z","timestamp":1780527121367,"version":"3.54.1"},"reference-count":47,"publisher":"Becaris Publishing Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Comp. Eff. Res."],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:p>\n            <jats:bold>Aim:<\/jats:bold>\n            According to the results of the MASTRO I living systematic review and meta-analysis, use of the EmboTrap Revascularization\n            <jats:sup>\u00ae<\/jats:sup>\n            Device in the treatment of acute ischemic stroke (AIS) results in higher rates of good functional outcomes (90-day modified Rankin Scale [mRS] 0\u20132) compared with use of the Trevo\n            <jats:sup>\u00ae<\/jats:sup>\n            Retriever or the Solitaire\u2122 Revascularization Device. The aim of this analysis was to assess the potential economic impact of achieving improved functional outcomes for three commonly used stent retrievers (SRs) in the treatment of AIS.\n            <jats:bold>Methods:<\/jats:bold>\n            An economic model with short-term and long-term costs, representing a healthcare system perspective was developed using a decision tree to simulate a cohort of 1000 hypothetical patients treated for AIS with mechanical thrombectomy (MT) using EmboTrap, Trevo or Solitaire SRs. Based on the proportion of patients who achieved a 90-day mRS score of 0\u20132 or 3\u20135 for each device reported in MASTRO I (excluding patients not surviving after 90\u00a0days), this model estimated per-patient costs and the associated incremental cost savings. Results are reported from the healthcare system perspective in the US, Canada, the UK, Sweden, Germany, France, Italy, Spain, Belgium and The Netherlands.\n            <jats:bold>Results:<\/jats:bold>\n            Across all ten countries, the use of EmboTrap during MT was associated with the lowest short-term (ranging from \u20ac8412 in Italy to $66,525 in the US), long-term (ranging from \u20ac5249 in Italy to $25,757 in the US) and total (ranging from \u20ac13,661 in Italy to $92,282 in the US) per-patient costs. The total per-patient cost was higher with Trevo (ranging from \u20ac14,601 in Italy to $97,487 in the US) and Solitaire (ranging from \u20ac14,840 in Italy to $98,814 in the US). Cost savings were highest when comparing EmboTrap versus Solitaire, followed by EmboTrap versus Trevo, with Trevo versus Solitaire having the smallest cost savings. Results of sensitivity and scenario analyses supported the robustness of the base-case results.\n            <jats:bold>Conclusion:<\/jats:bold>\n            Across the ten countries, treating patients with AIS with EmboTrap resulted in lower short-term, long-term and total costs to the payer. With rising healthcare costs and limited hospital budgets, these results suggest EmboTrap proves to be an evidence-based economical choice of SR for hospitals and healthcare systems.\n          <\/jats:p>","DOI":"10.57264\/cer-2024-0216","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T08:55:26Z","timestamp":1739782526000},"source":"Crossref","is-referenced-by-count":3,"title":["The economic impact of stent retriever selection for acute ischemic stroke: a cost analysis of MASTRO I from the healthcare system perspective of the United States, Canada and eight European countries"],"prefix":"10.57264","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8202-7829","authenticated-orcid":false,"given":"Tommy","family":"Andersson","sequence":"first","affiliation":[{"name":"Medical Imaging, AZ Groeninge, 8500, Kortrijk, Belgium"},{"name":"Neuroradiology, Karolinska University Hospital &amp; Clinical Neuroscience Karolinska Institutet, 171 77, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8049-1203","authenticated-orcid":false,"given":"Hannes","family":"Nordmeyer","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, Klinikum Solingen, Solingen, Germany"},{"name":"School of Medicine, Department of Health, Witten\/Herdecke University, Witten, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5271-5524","authenticated-orcid":false,"given":"Waleed","family":"Brinjikji","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic, Rochester, MN 55902, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9039-2823","authenticated-orcid":false,"given":"Emilie","family":"Kottenmeier","sequence":"additional","affiliation":[{"name":"Johnson &amp; Johnson MedTech, Irvine, CA 92618, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3486-7652","authenticated-orcid":false,"given":"Mina","family":"Kabiri","sequence":"additional","affiliation":[{"name":"Johnson &amp; Johnson MedTech, Global Health Economics &amp; Market Access, Raynham, MA 02767, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1779-4276","authenticated-orcid":false,"given":"Shanti","family":"Scheffler","sequence":"additional","affiliation":[{"name":"Johnson &amp; Johnson MedTech, 6300 Zug, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0041-2833","authenticated-orcid":false,"given":"Patrick A","family":"Brouwer","sequence":"additional","affiliation":[{"name":"Johnson &amp; Johnson MedTech, Irvine, CA 92618, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7721-4774","authenticated-orcid":false,"given":"Mahmood","family":"Mirza","sequence":"additional","affiliation":[{"name":"Johnson &amp; Johnson MedTech, Irvine, CA 92618, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4881-4698","authenticated-orcid":false,"given":"Osama O","family":"Zaidat","sequence":"additional","affiliation":[{"name":"Mercy St Vincent Medical Center, Toledo, OH 43608, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"36897","reference":[{"issue":"8","key":"e_1_3_8_3_2","first-page":"e93","article-title":"Heart Disease and Stroke Statistics-2023 Update: a report from the American Heart Association","volume":"147","author":"Tsao CW","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI Heart Disease and Stroke Statistics-2023 Update: a report from the American Heart Association. Circulation 147(8), e93\u2013e621 (2023).","journal-title":"Circulation"},{"key":"e_1_3_8_4_2","unstructured":"World Health Organization. The top 10 causes of death. (Accessed: February 2024). https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death"},{"issue":"10","key":"e_1_3_8_5_2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","article-title":"GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"20","year":"2021","unstructured":"GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 20(10), 795\u2013820 (2021).","journal-title":"Lancet Neurol."},{"key":"e_1_3_8_6_2","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.91282","article-title":"Available therapeutics after a stroke: current and promising options","author":"Cruz Mart\u00ednez MY","year":"2020","unstructured":"Cruz Mart\u00ednez MY, Alejandra Cant\u00fa Salda\u00f1a K, Antonio Ibarra Arias JJ. Available therapeutics after a stroke: current and promising options. New Insight into Cerebrovascular Diseases - An Updated Comprehensive Review (2020).","journal-title":"New Insight into Cerebrovascular Diseases - An Updated Comprehensive Review"},{"issue":"2","key":"e_1_3_8_7_2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.rehab.2014.09.017","article-title":"Stroke management: informal caregivers' burdens and strians of caring for stroke survivors","volume":"58","author":"Gbiri CA","year":"2015","unstructured":"Gbiri CA, Olawale OA, Isaac SO. Stroke management: informal caregivers' burdens and strians of caring for stroke survivors. Ann. Phys. Rehabil. Med. 58(2), 98\u2013103 (2015).","journal-title":"Ann. Phys. Rehabil. Med."},{"issue":"19","key":"e_1_3_8_8_2","doi-asserted-by":"crossref","first-page":"e558","DOI":"10.1161\/CIR.0000000000000570","article-title":"Projected costs of informal caregiving for cardiovascular disease: 2015 to 2035: a policy statement from the American Heart Association","volume":"137","author":"Dunbar SB","year":"2018","unstructured":"Dunbar SB, Khavjou OA, Bakas T Projected costs of informal caregiving for cardiovascular disease: 2015 to 2035: a policy statement from the American Heart Association. Circulation 137(19), e558\u2013e577 (2018).","journal-title":"Circulation"},{"issue":"8","key":"e_1_3_8_9_2","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 Heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"149","author":"Martin SS","year":"2024","unstructured":"Martin SS, Aday AW, Almarzooq ZI 2024 Heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation 149(8), e347\u2013e913 (2024).","journal-title":"Circulation"},{"issue":"11","key":"e_1_3_8_10_2","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1161\/STROKEAHA.123.043369","article-title":"Attributable costs of stroke in Ontario, Canada and their variation by stroke type and social determinants of health","volume":"54","author":"Vyas MV","year":"2023","unstructured":"Vyas MV, Fang J, de Oliveira C Attributable costs of stroke in Ontario, Canada and their variation by stroke type and social determinants of health. Stroke 54(11), 2824\u20132831 (2023).","journal-title":"Stroke"},{"issue":"1","key":"e_1_3_8_11_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/2396987319883160","article-title":"Economic burden of stroke across Europe: a population-based cost analysis","volume":"5","author":"Luengo-Fernandez R","year":"2020","unstructured":"Luengo-Fernandez R, Violato M, Candio P, Leal J. Economic burden of stroke across Europe: a population-based cost analysis. Eur. Stroke J. 5(1), 17\u201325 (2020).","journal-title":"Eur. Stroke J."},{"issue":"1","key":"e_1_3_8_12_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40809-016-0022-5","article-title":"Occurrence of intracranial large vessel occlusion in consecutive, non-referred patients with acute ischemic stroke","volume":"2","author":"Beumer D","year":"2016","unstructured":"Beumer D, Mulder MJHL, Saiedie G Occurrence of intracranial large vessel occlusion in consecutive, non-referred patients with acute ischemic stroke. Neurovasc. Imaging 2(1), 1\u20136 (2016).","journal-title":"Neurovasc. Imaging"},{"key":"e_1_3_8_13_2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3389\/fneur.2017.00651","article-title":"Ischemic strokes due to large-vessel occlusions contribute disproportionately to stroke-related dependence and death: a review","volume":"8","author":"Malhotra K","year":"2017","unstructured":"Malhotra K, Gornbein J, Saver JL. Ischemic strokes due to large-vessel occlusions contribute disproportionately to stroke-related dependence and death: a review. Front. Neurol. 8, 651 (2017).","journal-title":"Front. Neurol."},{"issue":"12","key":"e_1_3_8_14_2","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1161\/STROKEAHA.109.561787","article-title":"Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA","volume":"40","author":"Smith WS","year":"2009","unstructured":"Smith WS, Lev MH, English JD Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA. Stroke 40(12), 3834\u20133840 (2009).","journal-title":"Stroke"},{"issue":"12","key":"e_1_3_8_15_2","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"50","author":"Powers WJ","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 50(12), e344\u2013e418 (2019).","journal-title":"Stroke"},{"issue":"8","key":"e_1_3_8_16_2","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1136\/neurintsurg-2018-014569","article-title":"European Stroke Organisation (ESO) \u2013 European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischemic stroke","volume":"15","author":"Turc G","year":"2023","unstructured":"Turc G, Bhogal P, Fischer U European Stroke Organisation (ESO) \u2013 European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischemic stroke. J. NeuroIntervent. Surg. 15(8), e8 (2023).","journal-title":"J. NeuroIntervent. Surg."},{"issue":"1","key":"e_1_3_8_17_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/cjn.2022.344","article-title":"Canadian stroke best practice recommendations: Acute stroke management, 7(th) Edition Practice Guidelines Update, 2022","volume":"51","author":"Heran M","year":"2024","unstructured":"Heran M, Lindsay P, Gubitz G Canadian stroke best practice recommendations: Acute stroke management, 7(th) Edition Practice Guidelines Update, 2022. Can. J. Neurol. Sci. 51(1), 1\u201331 (2024).","journal-title":"Can. J. Neurol. Sci."},{"issue":"4","key":"e_1_3_8_18_2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1017\/cjn.2016.30","article-title":"Mechanical thrombectomy in acute ischemic stroke: a systematic review","volume":"43","author":"Lambrinos A","year":"2016","unstructured":"Lambrinos A, Schaink AK, Dhalla I Mechanical thrombectomy in acute ischemic stroke: a systematic review. Can. J. Neurol. Sci. 43(4), 455\u2013460 (2016).","journal-title":"Can. J. Neurol. Sci."},{"issue":"2","key":"e_1_3_8_19_2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/STROKEAHA.120.031027","article-title":"Cost-effectiveness of mechanical thrombectomy for treatment of nonminor ischemic stroke across Europe","volume":"52","author":"Candio P","year":"2021","unstructured":"Candio P, Violato M, Leal J, Luengo-Fernandez R. Cost-effectiveness of mechanical thrombectomy for treatment of nonminor ischemic stroke across Europe. Stroke 52(2), 664\u2013673 (2021).","journal-title":"Stroke"},{"issue":"2","key":"e_1_3_8_20_2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/STROKEAHA.116.014735","article-title":"Cost-effectiveness of Solitaire stent retriever thrombectomy for acute ischemic stroke: Results from the SWIFT-PRIME Trial (Solitaire with the intention for thrombectomy as primary endovascular treatment for acute ischemic stroke)","volume":"48","author":"Shireman TI","year":"2017","unstructured":"Shireman TI, Wang K, Saver JL Cost-effectiveness of Solitaire stent retriever thrombectomy for acute ischemic stroke: Results from the SWIFT-PRIME Trial (Solitaire with the intention for thrombectomy as primary endovascular treatment for acute ischemic stroke). Stroke 48(2), 379\u2013387 (2017).","journal-title":"Stroke"},{"issue":"2","key":"e_1_3_8_21_2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/15910199221081243","article-title":"Stentrievers: an engineering review","volume":"29","author":"Ahmed SU","year":"2023","unstructured":"Ahmed SU, Chen X, Peeling L, Kelly ME. Stentrievers: an engineering review. Interv. Neuroradiol. 29(2), 125\u2013133 (2023).","journal-title":"Interv. Neuroradiol."},{"key":"e_1_3_8_22_2","doi-asserted-by":"publisher","DOI":"10.57264\/cer-2023-0001"},{"issue":"2","key":"e_1_3_8_23_2","first-page":"A26","article-title":"EP64\u2005Systematic review and analysis of pre-clinical side-by-side comparisons of EmboTrap versus Solitaire performance","volume":"13","author":"Mirza M","year":"2021","unstructured":"Mirza M, McCarthy R, Gilvarry M. EP64\u2005Systematic review and analysis of pre-clinical side-by-side comparisons of EmboTrap versus Solitaire performance. J. Neurointerv. Surg. 13(Suppl. 2), A26 (2021).","journal-title":"J. Neurointerv. Surg."},{"issue":"5","key":"e_1_3_8_24_2","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/STROKEAHA.117.020125","article-title":"Primary results of the multicenter ARISE II study (Analysis of revascularization in ischemic stroke with EmboTrap)","volume":"49","author":"Zaidat OO","year":"2018","unstructured":"Zaidat OO, Bozorgchami H, Rib\u00f3 M Primary results of the multicenter ARISE II study (Analysis of revascularization in ischemic stroke with EmboTrap). Stroke 49(5), 1107\u20131115 (2018).","journal-title":"Stroke"},{"issue":"9","key":"e_1_3_8_25_2","first-page":"e978","article-title":"Three-month modified Rankin Scale as a determinant of 5-year cumulative costs after ischemic stroke: an analysis of 11,136 patients in Korea","volume":"94","author":"Kim SE","year":"2020","unstructured":"Kim SE, Lee H, Kim JY Three-month modified Rankin Scale as a determinant of 5-year cumulative costs after ischemic stroke: an analysis of 11,136 patients in Korea. Neurology 94(9), e978\u2013e991 (2020).","journal-title":"Neurology"},{"issue":"4","key":"e_1_3_8_26_2","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/1747493017691984","article-title":"Modified Rankin scale as a determinant of direct medical costs after stroke","volume":"12","author":"Dewilde S","year":"2017","unstructured":"Dewilde S, Annemans L, Peeters A Modified Rankin scale as a determinant of direct medical costs after stroke. Int. J. Stroke 12(4), 392\u2013400 (2017).","journal-title":"Int. J. Stroke"},{"issue":"5","key":"e_1_3_8_27_2","doi-asserted-by":"crossref","first-page":"e004513","DOI":"10.1161\/JAHA.116.004513","article-title":"Observed cost and variations in short term cost-effectiveness of therapy for ischemic stroke in interventional management of stroke (IMS) III","volume":"6","author":"Simpson KN","year":"2017","unstructured":"Simpson KN, Simpson AN, Mauldin PD Observed cost and variations in short term cost-effectiveness of therapy for ischemic stroke in interventional management of stroke (IMS) III. J. Am. Heart. Assoc. 6(5), e004513 (2017).","journal-title":"J. Am. Heart. Assoc."},{"issue":"6","key":"e_1_3_8_28_2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1017\/S0317167100015638","article-title":"Impact of disability status on ischemic stroke costs in Canada in the first year","volume":"39","author":"Mittmann N","year":"2012","unstructured":"Mittmann N, Seung SJ, Hill MD Impact of disability status on ischemic stroke costs in Canada in the first year. Can. J. Neurol. Sci. 39(6), 793\u2013800 (2012).","journal-title":"Can. J. Neurol. Sci."},{"issue":"8","key":"e_1_3_8_29_2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/13696998.2016.1174868","article-title":"Cost-effectiveness of stent-retriever thrombectomy in combination with IV t-PA compared with IV t-PA alone for acute ischemic stroke in the UK","volume":"19","author":"Lobotesis K","year":"2016","unstructured":"Lobotesis K, Veltkamp R, Carpenter IH Cost-effectiveness of stent-retriever thrombectomy in combination with IV t-PA compared with IV t-PA alone for acute ischemic stroke in the UK. J. Med. Econ. 19(8), 785\u2013794 (2016).","journal-title":"J. Med. Econ."},{"issue":"5","key":"e_1_3_8_30_2","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/ana.26602","article-title":"Economic evaluation of a mobile stroke unit service in Germany","volume":"93","author":"Oliveira Gon\u00e7alves ASO","year":"2023","unstructured":"Oliveira Gon\u00e7alves ASO, Rohmann JL, Piccininni M Economic evaluation of a mobile stroke unit service in Germany. Ann. Neurol. 93(5), 942\u2013951 (2023).","journal-title":"Ann. Neurol."},{"issue":"3","key":"e_1_3_8_31_2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neurol.2019.06.007","article-title":"Cost-effectiveness of stent-retriever thrombectomy in large vessel occlusion strokes of the anterior circulation: analysis from the French societal perspective","volume":"176","author":"Barral M","year":"2020","unstructured":"Barral M, Armoiry X, Boudour S Cost-effectiveness of stent-retriever thrombectomy in large vessel occlusion strokes of the anterior circulation: analysis from the French societal perspective. Rev. Neurol. (Paris) 176(3), 180\u2013188 (2020).","journal-title":"Rev. Neurol. (Paris)"},{"key":"e_1_3_8_32_2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-2377-12-137","article-title":"The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study","volume":"12","author":"Fattore G","year":"2012","unstructured":"Fattore G, Torbica A, Susi A The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study. BMC Neurol. 12, 137 (2012).","journal-title":"BMC Neurol."},{"issue":"3","key":"e_1_3_8_33_2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/2396987317721865","article-title":"Cost-effectiveness of mechanical thrombectomy using stent retriever after intravenous tissue plasminogen activator compared with intravenous tissue plasminogen activator alone in the treatment of acute ischaemic stroke due to large vessel occlusion in Spain","volume":"2","author":"de Andr\u00e9s-Nogales F","year":"2017","unstructured":"de Andr\u00e9s-Nogales F, \u00c1lvarez M, de Miquel M Cost-effectiveness of mechanical thrombectomy using stent retriever after intravenous tissue plasminogen activator compared with intravenous tissue plasminogen activator alone in the treatment of acute ischaemic stroke due to large vessel occlusion in Spain. Eur. Stroke J. 2(3), 272\u2013284 (2017).","journal-title":"Eur. Stroke J."},{"issue":"4","key":"e_1_3_8_34_2","doi-asserted-by":"crossref","first-page":"e0174861","DOI":"10.1371\/journal.pone.0174861","article-title":"Relationship between functional disability and costs one and two years post stroke","volume":"12","author":"Lekander I","year":"2017","unstructured":"Lekander I, Willers C, von Euler M Relationship between functional disability and costs one and two years post stroke. PLoS One 12(4), e0174861 (2017).","journal-title":"PLoS One"},{"issue":"4","key":"e_1_3_8_35_2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jval.2024.01.001","article-title":"Cost and utility estimates per modified rankin scale score up to 2 years post stroke: data to inform economic evaluations from a societal perspective","volume":"27","author":"Pinckaers FME","year":"2024","unstructured":"Pinckaers FME, Grutters JPC, Huijberts I Cost and utility estimates per modified rankin scale score up to 2 years post stroke: data to inform economic evaluations from a societal perspective. Value Health 27(4), 441\u2013448 (2024).","journal-title":"Value Health"},{"key":"e_1_3_8_36_2","doi-asserted-by":"crossref","unstructured":"OECD. Purchasing power parities (PPP) (indicator). doi: 10.1787\/1290ee5a-en (2017).","DOI":"10.1787\/1290ee5a-en"},{"key":"e_1_3_8_37_2","unstructured":"IMF Data. Country Indexes And Weight. (Accessed: October 2023). https:\/\/data.imf.org\/regular.aspx?key=61015892"},{"key":"e_1_3_8_38_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/CEOR.S95662","article-title":"Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke","volume":"8","author":"Johnson BH","year":"2016","unstructured":"Johnson BH, Bonafede MM, Watson C. Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke. Clinicoecon Outcomes Res. 8, 53\u201361 (2016).","journal-title":"Clinicoecon Outcomes Res."},{"issue":"2","key":"e_1_3_8_39_2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/ageing\/afz162","article-title":"Estimated societal costs of stroke in the UK based on a discrete event simulation","volume":"49","author":"Patel A","year":"2020","unstructured":"Patel A, Berdunov V, Quayyum Z Estimated societal costs of stroke in the UK based on a discrete event simulation. Age Ageing 49(2), 270\u2013276 (2020).","journal-title":"Age Ageing"},{"issue":"1","key":"e_1_3_8_40_2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13561-023-00439-6","article-title":"The costs associated with stroke care continuum: a systematic review","volume":"13","author":"Lucas-Noll J","year":"2023","unstructured":"Lucas-Noll J, Clua-Espuny JL, Lleixa-Fortuno M The costs associated with stroke care continuum: a systematic review. Health Econ. Rev. 13(1), 32 (2023).","journal-title":"Health Econ. Rev."},{"issue":"10","key":"e_1_3_8_41_2","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/jama.2018.1150","article-title":"Health care spending in the United States and other high-income countries","volume":"319","author":"Papanicolas I","year":"2018","unstructured":"Papanicolas I, Woskie LR, Jha AK. Health care spending in the United States and other high-income countries. JAMA 319(10), 1024\u20131039 (2018).","journal-title":"JAMA"},{"key":"e_1_3_8_42_2","doi-asserted-by":"crossref","first-page":"1064642","DOI":"10.3389\/fneur.2023.1064642","article-title":"Reliability of the modified Rankin scale in clinical practice of stroke units and rehabilitation wards","volume":"14","author":"Po\u017carowszczyk N","year":"2023","unstructured":"Po\u017carowszczyk N, Kurkowska-Jastrz\u0119bska I, Sarzy\u0144ska-D\u0142ugosz I, Nowak M, Karli\u0144ski M. Reliability of the modified Rankin scale in clinical practice of stroke units and rehabilitation wards. Front Neurol. 14, 1064642 (2023).","journal-title":"Front Neurol."},{"issue":"3","key":"e_1_3_8_43_2","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.STR.0000258355.23810.c6","article-title":"Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials","volume":"38","author":"Banks JL","year":"2007","unstructured":"Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials. Stroke 38(3), 1091\u20131096 (2007).","journal-title":"Stroke"},{"key":"e_1_3_8_44_2","first-page":"201","article-title":"Assessment scales in stroke: clinimetric and clinical considerations","volume":"8","author":"Harrison JK","year":"2013","unstructured":"Harrison JK, McArthur KS, Quinn TJ. Assessment scales in stroke: clinimetric and clinical considerations. Clin. Interv. Aging 8, 201\u2013211 (2013).","journal-title":"Clin. Interv. Aging"},{"issue":"7","key":"e_1_3_8_45_2","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/STROKEAHA.117.017866","article-title":"Evolution of the modified Rankin scale and its use in future stroke trials","volume":"48","author":"Broderick JP","year":"2017","unstructured":"Broderick JP, Adeoye O, Elm J. Evolution of the modified Rankin scale and its use in future stroke trials. Stroke 48(7), 2007\u20132012 (2017).","journal-title":"Stroke"},{"issue":"16","key":"e_1_3_8_46_2","doi-asserted-by":"crossref","first-page":"e025425","DOI":"10.1161\/JAHA.121.025425","article-title":"Repeated measures of modified Rankin scale scores to assess functional recovery from stroke: AFFINITY study findings","volume":"11","author":"Chye A","year":"2022","unstructured":"Chye A, Hackett ML, Hankey GJ Repeated measures of modified Rankin scale scores to assess functional recovery from stroke: AFFINITY study findings. Am. Heart J. 11(16), e025425 (2022).","journal-title":"Am. Heart J."},{"issue":"2","key":"e_1_3_8_47_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000517929","article-title":"The benefit of endovascular thrombectomy for stroke on functional outcome is sustained at 12 months","volume":"11","author":"Parameshwaran B","year":"2021","unstructured":"Parameshwaran B, Cordato D, Parsons M The benefit of endovascular thrombectomy for stroke on functional outcome is sustained at 12 months. Cerebrovasc. Dis. Extra 11(2), 81\u201386 (2021).","journal-title":"Cerebrovasc. Dis. Extra"},{"issue":"8","key":"e_1_3_8_48_2","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1111\/cns.14182","article-title":"Functional recovery continues beyond 3 months post-basilar artery thrombectomy: a retrospective cohort study","volume":"29","author":"Gunasekera L","year":"2023","unstructured":"Gunasekera L, Mitchell P, Dowling RJ, Bush S, Yan B. Functional recovery continues beyond 3 months post-basilar artery thrombectomy: a retrospective cohort study. CNS Neurosci. Ther. 29(8), 2171\u20132176 (2023).","journal-title":"CNS Neurosci. Ther."},{"issue":"3","key":"e_1_3_8_49_2","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1212\/CPJ.0000000000000954","article-title":"Variability of the modified Rankin scale score between day 90 and 1 year after ischemic stroke","volume":"11","author":"de Havenon A","year":"2021","unstructured":"de Havenon A, Tirschwell DL, Heitsch L Variability of the modified Rankin scale score between day 90 and 1 year after ischemic stroke. Neurol. Clin. Pract. 11(3), e239\u2013e244 (2021).","journal-title":"Neurol. Clin. Pract."}],"container-title":["Journal of Comparative Effectiveness Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/becarispublishing.com\/doi\/pdf\/10.57264\/cer-2024-0216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:44:39Z","timestamp":1739972679000},"score":1,"resource":{"primary":{"URL":"https:\/\/becarispublishing.com\/doi\/10.57264\/cer-2024-0216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.57264\/cer-2024-0216"],"URL":"https:\/\/doi.org\/10.57264\/cer-2024-0216","relation":{},"ISSN":["2042-6305","2042-6313"],"issn-type":[{"value":"2042-6305","type":"print"},{"value":"2042-6313","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"article-number":"e240216"}}